Skip to main content
Clinical Trials/ISRCTN96104919
ISRCTN96104919
Completed
Phase 2

Randomized controlled trial evaluating the efficacy of carrageenan as a topical microbicide against HPV Infection

Canadian Institutes of Health Research (CIHR) (Canada)0 sites461 target enrollmentMarch 7, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Canadian Institutes of Health Research (CIHR) (Canada)
Enrollment
461
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2019 Interim results article in https://pubmed.ncbi.nlm.nih.gov/29684633/ interim results (added 23/10/2020) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34487919/ (added 07/09/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37396806/ (added 04/07/2023)

Registry
who.int
Start Date
March 7, 2012
End Date
October 20, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Canadian Institutes of Health Research (CIHR) (Canada)

Eligibility Criteria

Inclusion Criteria

  • Added 01/03/2017: Current inclusion criteria as of 17/11/2014:
  • 1\. Female aged 18 or older living in Montreal
  • 2\. Plan to remain in Montreal for at least the next year
  • 3\. Have had vaginal sex with a male partner during the last 3 months and expect that they
  • will do so again in the next 3 months, regardless of whether or not the male partner(s) will
  • 4\. Not currently in a relationship that has lasted longer than 6 months
  • 5\. Be willing to follow study instructions
  • 6\. Understand French or English
  • 7\. Be willing to comply with follow\-up for at least 12 months
  • 8\. Have an intact uterus

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials